Strong sales of new products, notably HIV treatments, helps drugs giant Glaxo boost quarterly profits by a fifth

Britain's biggest drugs company posted a better-than-expected 19 per cent rise in core operating profit to £1.56billion for the first quarter, as sales increased by 11 per cent to £6.23billion.